Catalyst overview
Research summary
This catalyst tracks a Phase 1 data readout for VRDN-008 in No known indication. The expected timing is based on the latest available company guidance and may change.
11/2024- Half-life and PD data announced. Additional preclin data in 2025. 8/6/25- IND submission by YE 2025. 11/05/25:- IND filing remains on track for YE 2025; healthy volunteer data expected in 2H 2026. 02/26/26:- IND cleared Jan 2026; Ph1 healthy volunteer trial enrolling; Phase 1 data expected in H2 2026. 05/05/26:- Phase 1 healthy volunteer trial ongoing; data remains on track for second half of 2026. 08/06/26:- Phase 1 healthy volunteer data remains on track for H2 2026.
Verification
Confirm timing and program details against the company announcement or filing.